Studying virus genomes with next generation sequencing (NGS) can provide valuable information about viral spread and evolution. Targeted NGS is a valuable tool for both detection and characterization of viruses. Using very sensitive and accurate assays, we can monitor virus evolution, infection progression, and immune response. Hybridization capture and amplicon sequencing are both NGS techniques that are being used to fight SARS‑CoV‑2. We offer solutions to get researchers started using targeted NGS, featuring high performance and reproducibility, fast turnaround time, and endless customization and scalability.
Tools to sequence the virus are available through ARTICnetwork, a network of researchers that are developing a system for processing virus samples to generate public health information [1–3]. ARTIC provides a detailed protocol to quickly and accurately sequence SARS‑CoV‑2, featuring a set of primers for amplicon sequencing. We have partnered with ARTIC to produce a bulk set of these primers, which ensures availability and reproducibility.
Washington University in St Louis (WashU) is a part of the IDT Align℠ Preferred Partner Program. Through the McDonnell Genome Institute (MGI), WashU has been a long-standing collaborator with IDT and is committed to bringing you quality data and services. With multiple sequencing platforms at their disposal and access to all IDT NGS products, WashU is standing by to provide sequencing and preparation services for researchers, using their highly efficient, scalable research pipeline.
To learn more about WashU services, click here.